FDA has approved Genentechs ACTpen - a tocilizumab autoinjector 162 mg sc for use in RA, GCA, poly and systemic JIA - should be available in January 2019. https://t.co/YzFHyYxQlS

• https://buff.ly/2FIBVvS

Study of 2053 RA patients from VA medical centers found 27% with chronic lung disease that confered a 51% increased mortality risk; sadly this was not altered by MTX or biologic therapy. https://t.co/nYFnScSXQ4

• https://buff.ly/2TNuFlt

I prefer more slides with less data per slide rather than fewer slides jam packed with multiple miniscule figures #ASH18

We are not only doctors for the elderly. Many of our patients are young or even children. Sometimes we treat banal conditions but also we manage severe & autoimmune disorders with systemic involvement. We use innovative therapies. Didn't you know us? We are the Rheumatologists

This is a great conference! https://t.co/GEDlj44jLE

• Leonard Calabrese on Twitter: "Join me in Scottsdale for the 7th annual im…

2017 US life expectancy decreased for the 3rd year in a row. Drug overdoses & suicides lead the trend, resulting in earlier deaths and how long people live. Life expectancy dropped 78.7 yrs in 2016 to 78.6 yrs in 2017, with changes in men; not women https://t.co/gUParIkR6W

• https://buff.ly/2E7HrGK

Dont Miss the Next Best Meeting in Rheumatology - RHEUMNOW LIVE - March 22-24 2019 in beautiful downtown Fort Worth. Short Lectures, interactive sessions, Q&A panels, TED (like) Talks, digital, streaming and much more. You dont want to miss this meeting! https://t.co/5TVg0Frsbf

• https://buff.ly/2qX0Mlp

The RheumNow Podcast is Up! To Needle or Not to Needle; Watch https://t.co/pjYZh5LXzi or listent to the weekly news and review https://t.co/AmXgjki2dL

• https://buff.ly/2KKHOrl
• https://buff.ly/2BJun7W

296 women with HTN during pregnancy (half/147 NSAID-exposed) - NSAID use was not associated with a significant change in BP (vs no NSAID) and there was no added need to start or increase BP meds in those on NSAIDS. https://t.co/csDljBJI3r

• https://buff.ly/2zRpc3w

AstraZeneca today announced the FDA has granted Orphan Drug Status for Fasenra (benralizumab) for Eosinophilic Granulomatosis with Polyangiitis (EGPA). Fasenra is also approved for severe, eosinophilic asthma https://t.co/4ChX8D5Evx

• https://buff.ly/2So5EvB

Cohort VAMC study shows that Diabetes management (A1C, LDL, HTN) (n=368,481 patients) and outcomes were the same between physicians (n 3487), nurse practitioners (1445) and physician assistants (443). https://t.co/ToNVcPrMZN

• https://buff.ly/2TuUl5V

Amyotrophic lateral sclerosis, AKA Lou Gehrig’s dz (ALS), a progressive/fatal neuromuscular dz has an estimated prevalence of 5.2 per 100,000 - with a total of 16,583 cases identified. The majority of ALS patients die within 2–5 years of a diagnosis. https://t.co/Yg7aIspfnN

• https://buff.ly/2FBf2u6